Pot ‘Poster Child’ Eyes March Rollout for Alzheimer's Product
- IGC plans to bring low-dose THC formula to Canada next year
- Stock has surged more than 300% this year on cannabis plans
This article is for subscribers only.
As Canada today becomes the second country to fully legalize the recreational use of marijuana, the “poster child of a cannabis bubble” sees big opportunity ahead.
“Today was monumental,” India Globalization Capital’s Chief Executive Officer Ram Mukunda said in an interview. But the company is looking ahead to March, when it hopes to get its low-dose THC-based formulation for Alzheimer’s disease to the Canadian market.